trending Market Intelligence /marketintelligence/en/news-insights/trending/S0k7WKCB5feLP3xYJJ4cog2 content esgSubNav
In This List

Cellect Biotechnology appoints directors

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Cellect Biotechnology appoints directors

Cellect Biotechnology Ltd. appointed David Braun and Ruhama Avraham directors of the company.

Braun's term will last until the Israel-based company's next annual general meeting. Avraham will served as an external director for a three-year term ending Dec. 12, 2020.

Braun previously served as head of medical device business at Merck KGaA. Avraham is an external director of Minrav Holdings Ltd. and previously served as Israel's minister of tourism.